The aim of this study was to assess whether TRIZIVIR, administered twice-daily was as safe,
tolerable and efficacious as a combination of the drugs COMBIVIR administered twice-daily
and atazanavir administered once daily. Over the course of 48 weeks, various parameters that
measure safety, tolerability and efficacy of the investigational drugs were measured and
compared.
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
GSK Investigational Site, Bakersfield, California 93301, United States
GSK Investigational Site, Los Angeles, California 90069, United States
GSK Investigational Site, Oakland, California 94609, United States
GSK Investigational Site, San Francisco, California 94121, United States
GSK Investigational Site, Fort Collins, Colorado 80528, United States
GSK Investigational Site, Washington, District of Columbia 20007, United States
GSK Investigational Site, Fort Lauderdale, Florida 33145, United States
GSK Investigational Site, Fort Lauderdale, Florida 33306, United States
GSK Investigational Site, Fort Lauderdale, Florida 33308, United States
GSK Investigational Site, Fort Myers, Florida 33901, United States
GSK Investigational Site, Miami Beach, Florida 33140, United States
GSK Investigational Site, Miami, Florida 33136, United States
GSK Investigational Site, Orlando, Florida 32804, United States
GSK Investigational Site, Atlanta, Georgia 30339, United States
GSK Investigational Site, Decatur, Georgia 30033, United States
GSK Investigational Site, Chicago, Illinois 60637, United States
GSK Investigational Site, Guadalajara, Jalisco 44340, Mexico
GSK Investigational Site, Wichita, Kansas 67214, United States
GSK Investigational Site, Louisville, Kentucky 40202, United States
GSK Investigational Site, New Orleans, Louisiana 70115, United States
GSK Investigational Site, New Orleans, Louisiana 70127-0800, United States
GSK Investigational Site, New Orleans, Louisiana 70112, United States
GSK Investigational Site, St. Louis, Missouri 63139, United States
GSK Investigational Site, East Orange, New Jersey 7017, United States
GSK Investigational Site, Hillsborough, New Jersey 08876, United States
GSK Investigational Site, Newark, New Jersey 7102, United States
GSK Investigational Site, Voorhees, New Jersey 08043, United States
GSK Investigational Site, Mount Vernon, New York 10550, United States
GSK Investigational Site, Valhalla, New York 10595, United States
GSK Investigational Site, Charlotte, North Carolina 28209, United States
GSK Investigational Site, Greenville, North Carolina 27858-4354, United States
GSK Investigational Site, Monterrey, Nuevo León 64460, Mexico
GSK Investigational Site, Akron, Ohio 44304, United States
GSK Investigational Site, Portland, Oregon 97219, United States
GSK Investigational Site, Allentown, Pennsylvania 18102, United States
GSK Investigational Site, Philadelphia, Pennsylvania 19140, United States
GSK Investigational Site, West Reading, Pennsylvania 19611, United States
GSK Investigational Site, Columbia, South Carolina 29203, United States
GSK Investigational Site, Greenville, South Carolina 29605, United States
GSK Investigational Site, Austin, Texas 78705, United States
GSK Investigational Site, Dallas, Texas 75246, United States
GSK Investigational Site, Dallas, Texas 75208, United States
GSK Investigational Site, Harlingen, Texas 78550, United States
GSK Investigational Site, Houston, Texas 77027, United States
GSK Investigational Site, Hampton, Virginia 23666, United States